The association of hepatitis C virus infection and thyroid disease: A systematic review and meta-analysis.

IF 2.3 4区 医学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Hongpeng Wang, Yixiu Liu, Yanguang Zhao
{"title":"The association of hepatitis C virus infection and thyroid disease: A systematic review and meta-analysis.","authors":"Hongpeng Wang,&nbsp;Yixiu Liu,&nbsp;Yanguang Zhao","doi":"10.1177/17246008211056959","DOIUrl":null,"url":null,"abstract":"<p><p>Previous studies have reported that hepatitis C virus (HCV) infection may increase the risk of thyroid disease (TD) even thyroid cancer (TC), but quantitative assessments of risk were rare and the results were not consistent. The purpose of this study was to evaluate the impact of HCV infection on TD and TC, and provide clues to explore the relationship between HCV infection and TD and TC. The literature retrieval was performed up to August 20th, 2021 in the database of PubMed, Cochrane library, Web of Science, China National Knowledge Infrastructure and Wang Fang. The risk of HCV for TD or TC was expressed with odds ratio (OR) and 95% confidence intervals (CI). Subgroup analysis was used to explore the source of heterogeneity. Six articles (three studies published as article and three studies published as abstract) were included in this meta-analysis, with a total of 5398 controls and 1925 cases of hepatitis C. The results of meta-analysis found that HCV infection were significantly associated with an increased risk of TD (sum OR = 1.80, 95% CI = 1.54-2.10, <i>P</i> <  0.001, <i>I</i><sup>2</sup> = 74.3%) and TC (sum OR = 16.36, 95% CI = 4.65-57.62, <i>P</i> < 0.001, <i>I</i><sup>2</sup> = 0%). HCV infection may increase the risk of TD and TC. More work is needed in the future to establish a causal role, however an awareness of the possibility of increased risk of TD and TC may lead to earlier diagnosis and better outcomes in patients with hepatitis C.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":"36 4","pages":"3-9"},"PeriodicalIF":2.3000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Biological Markers","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17246008211056959","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/11/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Previous studies have reported that hepatitis C virus (HCV) infection may increase the risk of thyroid disease (TD) even thyroid cancer (TC), but quantitative assessments of risk were rare and the results were not consistent. The purpose of this study was to evaluate the impact of HCV infection on TD and TC, and provide clues to explore the relationship between HCV infection and TD and TC. The literature retrieval was performed up to August 20th, 2021 in the database of PubMed, Cochrane library, Web of Science, China National Knowledge Infrastructure and Wang Fang. The risk of HCV for TD or TC was expressed with odds ratio (OR) and 95% confidence intervals (CI). Subgroup analysis was used to explore the source of heterogeneity. Six articles (three studies published as article and three studies published as abstract) were included in this meta-analysis, with a total of 5398 controls and 1925 cases of hepatitis C. The results of meta-analysis found that HCV infection were significantly associated with an increased risk of TD (sum OR = 1.80, 95% CI = 1.54-2.10, P <  0.001, I2 = 74.3%) and TC (sum OR = 16.36, 95% CI = 4.65-57.62, P < 0.001, I2 = 0%). HCV infection may increase the risk of TD and TC. More work is needed in the future to establish a causal role, however an awareness of the possibility of increased risk of TD and TC may lead to earlier diagnosis and better outcomes in patients with hepatitis C.

丙型肝炎病毒感染与甲状腺疾病的相关性:一项系统综述和荟萃分析
以往的研究报道,丙型肝炎病毒(HCV)感染可增加甲状腺疾病(TD)甚至甲状腺癌(TC)的风险,但对风险的定量评估很少,结果也不一致。本研究旨在评价HCV感染对TD和TC的影响,为探讨HCV感染与TD和TC的关系提供线索。在PubMed、Cochrane图书馆、Web of Science、中国知识基础设施和王芳数据库中检索截至2021年8月20日的文献。用比值比(or)和95%置信区间(CI)来表达TD或TC的HCV风险。采用亚组分析探讨异质性的来源。本荟萃分析纳入6篇文献(3篇以论文形式发表,3篇以摘要形式发表),共纳入5398例对照和1925例丙型肝炎患者。荟萃分析结果发现,HCV感染与TD (sum OR = 1.80, 95% CI = 1.54-2.10, Pⅱ= 74.3%)和TC (sum OR = 16.36, 95% CI = 4.65-57.62, Pⅱ= 0%)风险增加显著相关。丙型肝炎病毒感染可增加TD和TC的风险。未来需要更多的工作来确定因果关系,然而,认识到TD和TC风险增加的可能性可能会导致丙型肝炎患者的早期诊断和更好的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Biological Markers
International Journal of Biological Markers 医学-生物工程与应用微生物
CiteScore
4.10
自引率
0.00%
发文量
43
期刊介绍: IJBM is an international, online only, peer-reviewed Journal, which publishes original research and critical reviews primarily focused on cancer biomarkers. IJBM targets advanced topics regarding the application of biomarkers in oncology and is dedicated to solid tumors in adult subjects. The clinical scenarios of interests are screening and early diagnosis of cancer, prognostic assessment, prediction of the response to and monitoring of treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信